Predicting Pathological Response to Preoperative Chemotherapy in Pancreatic Ductal Adenocarcinoma Using Post-Chemotherapy Computed Tomography Radiomics-Reference-Cited by-同舟云学术

Predicting Pathological Response to Preoperative Chemotherapy in Pancreatic Ductal Adenocarcinoma Using Post-Chemotherapy Computed Tomography Radiomics

Published:2024-01-13 Issue: Volume: Page:
ISSN:2168-8184
Container-title:Cureus
language:en
Short-container-title:

Author:

Ikuta Shinichi,Aihara Tsukasa,Nakajima Takayoshi,Yamanaka Naoki

Publisher

Springer Science and Business Media LLC

Reference30 articles.

1. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung H;CA Cancer J Clin,2021

2. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States;Rahib L;Cancer Res,2014

3. Cancer statistics, 2022;Siegel RL;CA Cancer J Clin,2022

4. The effect of neoadjuvant chemotherapy with gemcitabine and S-1 for resectable pancreatic cancer (randomized phase II/III trial Prep-02/JSAP-05);Satoi S;J Clin Oncol,2019

5. Oncological benefits of neoadjuvant chemoradiation with gemcitabine versus upfront surgery in patients with borderline resectable pancreatic cancer: a prospective, randomized, open-label, multicenter phase 2/3 trial;Jang JY;Ann Surg,2018

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cystic pancreatic neoplasms: what we need to know and new perspectives;Journal of Medical Imaging and Interventional Radiology;2024-08-16

2. Novel machine‐learning model for predicting lymph node metastasis in resectable pancreatic ductal adenocarcinoma;Annals of Gastroenterological Surgery;2024-06-17